Essex LLC Annovis Bio, Inc. Transaction History

Essex LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$8.61 - $13.87 $10,202 - $16,435	-1,185 Reduced 10.22%	10,408 $118,000
Q1 2022 Apr 20, 2022	BUY	$11.84 - $19.78 $11,840 - $19,780	1,000 Added 9.44%	11,593 $155,000
Q4 2021 Jan 28, 2022	SELL	$17.58 - $37.67 $24,067 - $51,570	-1,369 Reduced 11.44%	10,593 $186,000
Q3 2021 Oct 21, 2021	BUY	$30.95 - $120.97 $370,223 - $1.45 Million	11,962 New	11,962 $380,000

1.17M

229K

934K

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $44M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

Stay updated on Essex LLC with notifications on news.